Fundraising Fox
🦊/Companies
Sign in

Evergreen Theragnostics

Chatham, US · Founded 2019 · Delaware corporation · 2 known investors

Find your way into Evergreen Theragnostics

Biotech

Founders & leadership

GB
Gerard BerNamed on SEC filing
SL
Serge LyashchenkoNamed on SEC filing
VP
Victor PaulusNamed on SEC filing
JC
James CookNamed on SEC filing

Board

EDEnrico De Maria
Enrico De MariaBoard directorInvestment Committee Member at LIFTT

Investors · 2

LIFTTTorino

Also in the syndicate · 1

Petrichor

Funding

SEC filings, press & company announcements

$60.9M disclosed across 3 of 4 rounds · 2020–2026

▶$15.5MraisedAug 2023 · 58 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Serge LyashchenkoDirector
  • Sharon RodedDirector
  • Enrico De MariaDirector
  • Gerard BerDirector
  • James CookExecutive Officer, Director
Offering amount
$15.5M
Amount sold
$15.5M
First sale
Dec 2022
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$19.5MraisedJun 2020 · 76 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Gerard BerDirector
  • Serge LyashchenkoDirector
  • Enrico De MariaDirector
  • Victor PaulusDirector
  • James CookExecutive Officer, Director
Offering amount
$25M
Amount sold
$19.5M
First sale
Apr 2020
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Evergreen Theragnostics Raises $26M in Capital to Aid Commercialization Efforts for the Ga-68 DOTATOC Diagnostic Kit | Pharmaceutical Commercepharmaceuticalcommerce.com · Mar 2026Evergreen Theragnostics Raises $26M, Boosting Radiopharma and CDMO Capabilities - PharmaSourcepharmasource.global · Apr 2024Evergreen Theragnostics Completes $26M Capital Raise to Advance Novel Radiopharmaceutical Pipeline into the Clinic, Prepare for First Commercial Product Launch, and Expand Industry-Leading CDMO Servicesprnewswire.com · Apr 2024Evergreen Theragnostics Completes $26M Fundingfinsmes.com · Apr 2024Evergreen Theragnostics Raises $15 Million in Series B Round | citybizcitybiz.co · Mar 2023Evergreen Theragnostics Completes $15M Series B, Launches Discovery Unit, and Prepares Ga-68 DOTATOC Supply Chain | FirstWord Pharmafirstwordpharma.com · Mar 2023

Frequently asked questions

Who are Evergreen Theragnostics's investors?
Evergreen Theragnostics's investors include LIFTT.
How much funding has Evergreen Theragnostics raised?
Evergreen Theragnostics has disclosed $60.9M raised across 3 of its 4 known rounds.
Where is Evergreen Theragnostics headquartered?
Evergreen Theragnostics is headquartered in Chatham, US.